Premium
O4‐12‐02: Tideglusib, a GSK‐3 inhibitor, reduces progression of brain atrophy in progressive supranuclear palsy
Author(s) -
Hoglinger Gunter,
Huppertz HansJürgen,
Wagenpfeil Stefan,
Andrés María,
León Teresa,
Ser Teodoro
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.08.028
Subject(s) - progressive supranuclear palsy , atrophy , placebo , medicine , placebo controlled study , nuclear medicine , pathology , double blind , alternative medicine